Keyword

meropenem

Description: Meropenem is a broad-spectrum carbapenem antibiotic used to treat serious bacterial infections, including infections caused by resistant organisms.

Primary topic: Antibiotic Resistance in Bacteria (30%)

Wikidata ID: wiki/Q421670

OpenAlex ID: keywords/meropenem

Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

2001 · Hesna Yigit, Anne Marie Queenan, et al. · Antimicrobial Agents and Chemotherapy · 1,641

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

2009 · Patrice Nordmann, Gaelle Cuzon, et al. · The Lancet Infectious Diseases · 1,580

Carbapenems: Past, Present, and Future

2011 · Krisztina M. Papp-Wallace, Andrea Endimiani, et al. · Antimicrobial Agents and Chemotherapy · 1,512

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

2012 · M. Tumbarello, P. Viale, et al. · Clinical Infectious Diseases · 1,016

Recovery of gut microbiota of healthy adults following antibiotic exposure

2018 · Albert Palleja, Kristian H. Mikkelsen, et al. · Nature Microbiology · 870

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

2018 · Patrick N. A. Harris, Paul A. Tambyah, et al. · JAMA · 777

PDF

Comparative Review of the Carbapenems

2007 · George G Zhanel, Ryan Wiebe, et al. · Drugs · 655

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

2018 · Mical Paul, George L Daikos, et al. · The Lancet Infectious Diseases · 626

Rhino-Orbital Mucormycosis Associated With COVID-19

2020 · Salil Mehta, Abha Pandey · Cureus · 583

PDF

Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance

2014 · Andrew M. King, Sarah A. Reid-Yu, et al. · Nature · 554

Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study

2015 · Mario Tumbarello, Enrico Maria Trecarichi, et al. · Journal of Antimicrobial Chemotherapy · 513

PDF

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

2009 · Jean-Emmanuel Hugonnet, Lee W. Tremblay, et al. · Science · 494

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

2020 · Richard G Wunderink, Yuko Matsunaga, et al. · The Lancet Infectious Diseases · 478

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

2008 · Michael M. Tunney, Tyler R. Field, et al. · American Journal of Respiratory and Critical Care Medicine · 470

Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome

2016 · Molly K. Gibson, Bin Wang, et al. · Nature Microbiology · 454

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

2019 · George G. Zhanel, Alyssa R. Golden, et al. · Drugs · 443

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

2017 · Antoni Torres, Nanshan Zhong, et al. · The Lancet Infectious Diseases · 442

Biodegradability of Cefotiam, Ciprofloxacin, Meropenem, Penicillin G, and Sulfamethoxazole and Inhibition of Waste Water Bacteria

1999 · A. Al-Ahmad, F. D. Daschner, et al. · Archives of Environmental Contamination and Toxicology · 429

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

2015 · Joseph Solomkin, Ellie Hershberger, et al. · Clinical Infectious Diseases · 420

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

2011 · Joao Gonçalves-Pereira, Pedro Póvoa · Critical Care · 408

PDF

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

2016 · John E. Mazuski, Leanne B. Gasink, et al. · Clinical Infectious Diseases · 394

PDF

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

2012 · J. M. Dulhunty, J. A. Roberts, et al. · Clinical Infectious Diseases · 394

Of Pseudomonas, porins, pumps and carbapenems

2001 · D. M. Livermore · Journal of Antimicrobial Chemotherapy · 391

PDF

Early Antibiotic Treatment for Severe Acute Necrotizing Pancreatitis

2007 · E Patchen Dellinger, Jose M. Tellado, et al. · Annals of Surgery · 378

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

2010 · Fabio Silvio Taccone, Pierre-François Laterre, et al. · Critical Care · 369

PDF

Works count: 17,790

Citation count: 203,800